Literature DB >> 22936601

α-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signalling pathway.

Ruth E J Musgrove1, Anna E King, Tracey C Dickson.   

Abstract

α-Synuclein is a pre-synaptic chaperone and its accumulation contributes to differential cell loss in Parkinson's disease. Cytoplasmic expression of α-synuclein can directly modulate apoptotic pathways and contribute to cell survival, whereas induced over-expression of the protein causes oxidative stress through mitochondrial and cytosolic free-radical production. This study aimed to clarify the contribution of endogenous α-synuclein to oxidative stress and its association with cell death. Primary cortical neurons were derived from α-synuclein knock-out (Snca-/-) and wild-type (C57BL/6; WT) mice and treated with in vitro models of oxidative-stress, complex I inhibition and excitotoxicity. Mitochondrial free radical production was determined in isolated mitochondria derived from each mouse strain. Snca-/- derived cortical cultures were more susceptible (P < 0.05) to oxidative-stress, but not excitotoxicity. This result was determined by significant increases in cell death (Propidium-Iodide staining) after 6 h treatment in Snca-/- (45 % ± 2.7 SEM), relative to WT (33 % ± 3.9 SEM) cultures. α-Synuclein also confers significant (P < 0.05) resistance to low-dose (5 nM) rotenone toxicity, with a twofold reduction in cell death in WT, compared with Snca-/- cortical neurons. The expression of α-synuclein had no effect on cortical glutathione levels, or the production of reactive oxygen intermediates in isolated mitochondria. These data indicate that endogenous levels of α-synuclein confer resistance to oxidative stress downstream of free radical production and scavenging. The current data suggest that α-synuclein prevents cytochrome c release and apoptosis through inhibition of the MAPK signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936601     DOI: 10.1007/s12640-012-9352-5

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  54 in total

1.  Mice lacking alpha-synuclein are resistant to mitochondrial toxins.

Authors:  Peter Klivenyi; Donald Siwek; Gabrielle Gardian; Lichuan Yang; Anatoly Starkov; Carine Cleren; Robert J Ferrante; Neil W Kowall; Asa Abeliovich; M Flint Beal
Journal:  Neurobiol Dis       Date:  2005-11-18       Impact factor: 5.996

Review 2.  Controlling the mass action of alpha-synuclein in Parkinson's disease.

Authors:  Changyoun Kim; Seung-Jae Lee
Journal:  J Neurochem       Date:  2008-09-02       Impact factor: 5.372

3.  alpha-Synuclein affects the MAPK pathway and accelerates cell death.

Authors:  A Iwata; M Maruyama; I Kanazawa; N Nukina
Journal:  J Biol Chem       Date:  2001-09-17       Impact factor: 5.157

4.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

Authors:  N Ostrerova; L Petrucelli; M Farrer; N Mehta; P Choi; J Hardy; B Wolozin
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

5.  Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection.

Authors:  M C Quilty; A E King; W-P Gai; D L Pountney; A K West; J C Vickers; T C Dickson
Journal:  Exp Neurol       Date:  2005-11-28       Impact factor: 5.330

6.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

Authors:  Amy B Manning-Bog; Alison L McCormack; Jie Li; Vladimir N Uversky; Anthony L Fink; Donato A Di Monte
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

7.  Contribution of a mitochondrial pathway to excitotoxic neuronal necrosis.

Authors:  Dae-Won Seo; Maria-Leonor Lopez-Meraz; Suni Allen; Claude Guy Wasterlain; Jerome Niquet
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

Review 8.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

Authors:  Isaac G Onyango
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

9.  Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease.

Authors:  Cristine Alves Da Costa; Erwan Paitel; Bruno Vincent; Frédéric Checler
Journal:  J Biol Chem       Date:  2002-10-22       Impact factor: 5.157

10.  Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Authors:  Latha Devi; Vijayendran Raghavendran; Badanavalu M Prabhu; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

View more
  18 in total

1.  Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling.

Authors:  Kristi L Norris; Rui Hao; Liang-Fu Chen; Chun-Hsiang Lai; Meghan Kapur; Peter J Shaughnessy; Dennis Chou; Jin Yan; J Paul Taylor; Simone Engelender; Anna E West; Kah-Leong Lim; Tso-Pang Yao
Journal:  J Biol Chem       Date:  2015-04-10       Impact factor: 5.157

2.  Age-dependent alpha-synuclein accumulation is correlated with elevation of mitochondrial TRPC3 in the brains of monkeys and mice.

Authors:  Min Chen; Jia Liu; Yongquan Lu; Chunli Duan; Lingling Lu; Ge Gao; Piu Chan; Shun Yu; Hui Yang
Journal:  J Neural Transm (Vienna)       Date:  2016-11-30       Impact factor: 3.575

3.  Autophagy enhancement is rendered ineffective in presence of α-synuclein in melanoma cells.

Authors:  Swapna Nandakumar; Bejoy Vijayan; Asha Kishore; Anoopkumar Thekkuveettil
Journal:  J Cell Commun Signal       Date:  2017-07-26       Impact factor: 5.782

4.  MiR-19b alleviates MPP+-induced neuronal cytotoxicity via targeting the HAPLN4/MAPK pathway in SH-SY5Y cells.

Authors:  Wei Liu; Lijiao Geng; Yong Chen
Journal:  RSC Adv       Date:  2018-03-16       Impact factor: 4.036

5.  Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease.

Authors:  Rosa Resende; Sueli C F Marques; Elisabete Ferreiro; Isaura Simões; Catarina R Oliveira; Cláudia M F Pereira
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

Review 6.  α-Synuclein and mitochondria: partners in crime?

Authors:  Ken Nakamura
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

7.  Genetic risk prediction and neurobiological understanding of alcoholism.

Authors:  D F Levey; H Le-Niculescu; J Frank; M Ayalew; N Jain; B Kirlin; R Learman; E Winiger; Z Rodd; A Shekhar; N Schork; F Kiefer; F Kiefe; N Wodarz; B Müller-Myhsok; N Dahmen; M Nöthen; R Sherva; L Farrer; A H Smith; H R Kranzler; M Rietschel; J Gelernter; A B Niculescu
Journal:  Transl Psychiatry       Date:  2014-05-20       Impact factor: 6.222

8.  Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition.

Authors:  Gessica Sala; Alessandro Arosio; Giovanni Stefanoni; Laura Melchionda; Chiara Riva; Daniele Marinig; Laura Brighina; Carlo Ferrarese
Journal:  Biomed Res Int       Date:  2013-07-30       Impact factor: 3.411

Review 9.  Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence.

Authors:  Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Antonieta Mora-Tiscareño; Humberto Medina-Cortina; Ricardo Torres-Jardón; Michael Kavanaugh
Journal:  Biomed Res Int       Date:  2013-02-07       Impact factor: 3.411

10.  High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.

Authors:  Yan Kong; Xijun Liang; Lin Liu; Dongdong Zhang; Chao Wan; Zhenji Gan; Liudi Yuan
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.